Guidelines for the use of epoetin: have quality-of-life benefits been proven?

Andrew Bottomley, Ronald Thomas, Kristel Van Steen, Henning Flechtner, Alexander de Graeff

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2223; author reply 2224-5
JournalJournal of Clinical Oncology
Volume21
Issue number11
DOIs
Publication statusPublished - 1 Jun 2003

Keywords

  • Anemia
  • Erythropoietin
  • Humans
  • Neoplasms
  • Quality of Life
  • Recombinant Proteins

Cite this